Decreased β-Cell Function is Associated with Cardiovascular Autonomic Neuropathy in Chinese Patients Newly Diagnosed with Type 2 Diabetes

التفاصيل البيبلوغرافية
العنوان: Decreased β-Cell Function is Associated with Cardiovascular Autonomic Neuropathy in Chinese Patients Newly Diagnosed with Type 2 Diabetes
المؤلفون: Longyi Zeng, Yanhua Zhu, Hongrong Deng, Wen Xu, Jianping Weng, Xubin Yang, Ying Tan
المصدر: Neuroscience Bulletin
بيانات النشر: Springer Science and Business Media LLC, 2018.
سنة النشر: 2018
مصطلحات موضوعية: Adult, Blood Glucose, Male, 0301 basic medicine, medicine.medical_specialty, β-cell function, Physiology, medicine.medical_treatment, Population, Cardiovascular autonomic neuropathy, Type 2 diabetes, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Asian People, Diabetic Neuropathies, Insulin-Secreting Cells, Internal medicine, Type 2 diabetes mellitus, medicine, Humans, Insulin, education, education.field_of_study, Autonomic nerve, business.industry, General Neuroscience, food and beverages, Type 2 Diabetes Mellitus, Fasting, General Medicine, Middle Aged, medicine.disease, Glucose, 030104 developmental biology, Postprandial, Diabetes Mellitus, Type 2, Original Article, Female, Insulin Resistance, business, Complication, 030217 neurology & neurosurgery, Homeostasis
الوصف: The influence of β-cell function on cardiovascular autonomic neuropathy (CAN), an important diabetes-related complication, is still unclear. In this study, we aimed to investigate the association between residual β-cell function and CAN in patients newly diagnosed with type 2 diabetes. We enrolled 90 newly-diagnosed type 2 diabetic patients and 37 participants with normal glucose tolerance as controls. The patients were divided into a CAN+ group (diabetic patients with CAN, n = 20) and a CAN− group (diabetic patients without CAN, n = 70) according to the standard Ewing battery of tests. Fasting and postprandial plasma glucose, insulin, and C-peptide were measured. Homeostasis model assessment-beta cells (HOMA-B) and HOMA-insulin resistance (IR) were calculated. The prevalence of CAN in this population was 22.2%. Compared with the CAN− group, the CAN+ group had significantly lower fasting plasma insulin (6.60 ± 4.39 vs 10.45 ± 7.82 μ/L, P = 0.029), fasting C-peptide (0.51 ± 0.20 vs 0.82 ± 0.51 nmol/L, P = 0.004), and HOMA-B (21.44 ± 17.06 vs 44.17 ± 38.49, P = 0.002). Fasting C-peptide was correlated with the Valsalva ratio (r = 0.24, P = 0.043) and the 30:15 test (r = 0.26, P = 0.023). Further analysis showed that fasting C-peptide (OR: 0.041, 95% CI 0.003–0.501, P = 0.012) and HOMA-B (OR: 0.965, 95% CI 0.934–0.996, P = 0.028) were independently associated with cardiovascular autonomic nerve function in this population. The patients with fasting C-peptide values < 0.67 nmol/L were more likely to have CAN than those with C-peptide levels ≥0.67 nmol/L (OR: 6.00, 95% CI 1.815–19.830, P = 0.003). A high prevalence of CAN was found in patients with newly-diagnosed type 2 diabetes. Decreased β-cell function was closely associated with CAN in this population.
تدمد: 1995-8218
1673-7067
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82ab59663586a44cea66e2db1a22b25eTest
https://doi.org/10.1007/s12264-018-0304-9Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....82ab59663586a44cea66e2db1a22b25e
قاعدة البيانات: OpenAIRE